Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleBrentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsSteven Halpern